Manipal Health Enterprises Limited (NSE:MANIPALHOS)

NSE:MANIPALHOS Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Operating Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	8,923	10,654	5,943	4,222	5,419
Depreciation & Amortization	6,371	4,744	3,787	3,181	2,507
Other Amortization	424.51	324.35	183	94.42	53.1
Loss (Gain) From Sale of Assets	-12.64	4.18	-23.71	-7.53	-0.1
Asset Writedown & Restructuring Costs	-	-	1,141	-	-
Loss (Gain) From Sale of Investments	-1,196	-1,011	-801.66	-147.33	-354.4
Loss (Gain) on Equity Investments	-	-	-	291.09	215.2
Stock-Based Compensation	329.74	388.28	135.26	81.54	67.1
Provision & Write-off of Bad Debts	1,119	878.33	339.1	454.01	213.8
Other Operating Activities	6,475	3,525	2,818	2,845	3,406
Change in Accounts Receivable	-2,689	-1,903	-496.91	-581.76	-1,281
Change in Inventory	-206.29	-77.09	-230.89	144.12	-279.7
Change in Accounts Payable	458.02	-1,631	1,163	1,031	1,031
Change in Other Net Operating Assets	787.59	-144.59	-72.4	-86.96	-1,239
Operating Cash Flow	20,784	15,698	13,886	11,521	8,045
Operating Cash Flow Growth	32.40%	13.05%	20.54%	43.20%	-

Investing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Capital Expenditures	-13,162	-10,543	-3,319	-3,296	-1,758
Sale of Property, Plant & Equipment	43.52	48.48	49.59	22.22	0.1
Cash Acquisitions	-52,548	-10,129	-6,246	-	-17,103
Divestitures	-	-	-	-	4,071
Investment in Securities	-5,210	-6,067	792.33	-2,343	-2,378
Other Investing Activities	509.59	106.56	18.42	-4,335	56.6
Investing Cash Flow	-70,367	-26,583	-8,705	-9,952	-17,111

Financing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Short-Term Debt Issued	-	-	-	-	695.2
Long-Term Debt Issued	59,059	9,048	2,943	5,347	1,341
Total Debt Issued	59,059	9,048	2,943	5,347	2,036
Long-Term Debt Repaid	-4,164	-2,979	-2,967	-3,883	-1,092
Net Debt Issued (Repaid)	54,895	6,069	-23.94	1,464	944
Issuance of Common Stock	-	7,500	4,084	-	11,368
Other Financing Activities	-5,351	-4,528	-6,562	-2,916	-2,903
Financing Cash Flow	49,544	9,041	-2,502	-1,451	9,409

Net Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Foreign Exchange Rate Adjustments	-	-	-	-	0.3
Miscellaneous Cash Flow Adjustments	119.69	1,148	247.42	-	-
Net Cash Flow	80.69	-695.99	2,927	116.69	343.3

Free Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	7,622	5,155	10,567	8,224	6,287
Free Cash Flow Growth	47.85%	-51.21%	28.49%	30.81%	-
Free Cash Flow Margin	7.38%	6.25%	17.12%	16.99%	15.82%
Free Cash Flow Per Share	6.55	4.47	9.34	7.32	5.62
Levered Free Cash Flow	9,340	545.38	8,210	1,096	-
Unlevered Free Cash Flow	14,477	3,518	10,730	3,021	-

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash Interest Paid	5,351	4,528	3,781	2,662	2,908
Cash Income Tax Paid	4,221	2,899	2,914	1,973	936.2
Change in Working Capital	-1,649	-3,756	362.95	505.9	-1,769

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 10, 2026

Data Sources Report a data error